Standard BioTools Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
-3.33 | 35.84 | -109.3% | -4.39 | -24.08% |
| P/S |
|
3.58 | 127.81 | -97.2% |
|
|
| P/BV |
|
1.33 | 254.49 | -99.48% |
|
|
| P/FCF |
|
-3.05 | -175.22 | -98.26% |
|
|
| Ev/Ebitda |
|
-4.16 | -27.35 | -84.79% |
|
|
| Ev/S |
|
2.82 | 536.01 | -99.47% |
|
|
| Ev/FCF |
|
-3.24 | -282.71 | -98.85% |
|
|
| E/P |
|
-0.3 | 0.0223 | -1443.81% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-67.73 | -366.8 | -81.54% | -86.32 | -21.54% |
| ROE |
|
-43.75 | 104.34 | -141.93% |
|
|
| ROA |
|
-29.69 | -2.2 | 1249.79% |
|
|
| ROIC |
|
0 | 1.17 | -100% |
|
|
| ROS |
|
-79.62 | -291.82 | -72.72% |
|
|
| ROCE |
|
-28.62 | 3.23 | -987.23% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.28 | 0.97 | -128.88% | -0.65 | -56.8% |
| Nеt Debt/Ebitda |
|
1.13 | 1.05 | 7.79% |
|
|
| Debt/Ratio |
|
0.0539 | 0.18 | -70% |
|
|
| Debt/Equity |
|
0.3 | 1.59 | -81.26% |
|
|
| Debt/Net Income |
|
-0.24 | -1.48 | -83.95% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.55 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.8 | -100% | ||
| DSI |
|
0 | 0.22 | -100% |
|
|
| Average dividend growth |
|
0 | 1.88 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.52 | -100% |
|
|
| Average percentage for payments |
|
0 | 59.01 | -100% |
|
|
| Difference from average difference in sector |
|
-0.55 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
4/10
|
26.27 | -90.69 | -128.97% | ||
| Growth impulse Ebitda in 5 years |
|
241.38 | -121.55 | -298.58% | ||
| Growth impulse Net Income in 5 years |
|
161.95 | -104.46 | -255.04% | ||
| Growth impulse FCF in 5 years |
|
439.59 | -121.68 | -461.27% | ||
| Growth impulse EPS in 5 years |
|
-46.49 | -97.03 | -52.09% |
IP Score
4.38/10
